Literature DB >> 33189841

Ameliorative effects of ginsenosides on myelosuppression induced by chemotherapy or radiotherapy.

Mengjiao He1, Na Wang2, Wenxiu Zheng3, Xiaoqing Cai4, Dongmei Qi5, Yongqing Zhang6, Chunchao Han7.   

Abstract

BACKGROUND: and ethnopharmacological relevance: As the major side effect of radiotherapy or chemotherapy, myelosuppression usually leads to anemia, hemorrhage, immunosuppression, and even fatal infections, which may discontinue the process of cancer treatment. As a result, more and more attention is paid to the treatment of myelosuppression. Ginseng, root of Panax ginseng Meyer (Panax ginseng C. A. Mey), is considered as the king of herbs in the Orient, particularly in China, Korea and Japan. Ginsenosides, the most important active ingredients of ginseng, have been shown to have a variety of therapeutic effects, such as neuroprotective, anti-cancer and anti-diabetic properties. Considering that ginsenosides are closely associated with the pathogenesis of myelosuppression, researchers have carried out a few experiments on ginsenosides to attenuate myelosuppression induced by chemotherapy or radiotherapy in recent years. AIM OF THE STUDY: To summarize previous studies about the effects of ginsenosides on alleviating myelosuppression and the mechanisms of action.
METHODS: Literatures in this review were searched in PubMed, China National Knowledge Infrastructure (CNKI), Web of Science, and ScienceDirect.
RESULTS: Ginsenosides play an important role in relieving myelosuppression predominantly by restoring hematopoiesis and immunity.
CONCLUSION: Ginsenosides might be potential candidates for the treatment of myelosuppression induced by chemotherapy or radiotherapy.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Chemotherapy; Ginsenosides; Hematopoiesis; Immunity; Myelosuppression; Radiotherapy

Year:  2020        PMID: 33189841     DOI: 10.1016/j.jep.2020.113581

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  2 in total

1.  Effect of Shenqi Fuzheng Injection on Leukopenia and T-cell Subsets in Patients with Non-small Cell Lung Cancer Undergoing Radiotherapy.

Authors:  Chengde Wu; Ying Liang; Fangyong Fu
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-05       Impact factor: 2.650

2.  Oxidative Stress-Dependent Synergistic Antiproliferation, Apoptosis, and DNA Damage of Ultraviolet-C and Coral-Derived Sinularin Combined Treatment for Oral Cancer Cells.

Authors:  Sheng-Yao Peng; Jen-Yang Tang; Ruei-Nian Li; Hurng-Wern Huang; Chang-Yi Wu; Chien-Chih Chiu; Fang-Rong Chang; Hong-Wei Zhang; Yun-Jou Lee; Jyh-Horng Sheu; Hsueh-Wei Chang
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.